Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCollateralCommon EquityCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredReceivables - AffiliatesRetained EarningsSecurities BorrowedSecurities BoughtShareholder's EquityShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cohen (COHN) Cash & Equivalents (2016 - 2025)

Cohen (COHN) has disclosed Cash & Equivalents for 16 consecutive years, with $54.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Equivalents rose 282.7% year-over-year to $54.7 million, compared with a TTM value of $54.7 million through Sep 2025, up 282.7%, and an annual FY2024 reading of $19.6 million, up 83.94% over the prior year.
  • Cash & Equivalents was $54.7 million for Q3 2025 at Cohen, up from $26.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $62.5 million in Q1 2022 and bottomed at $3.6 million in Q1 2023.
  • Average Cash & Equivalents over 5 years is $27.3 million, with a median of $19.6 million recorded in 2024.
  • The sharpest move saw Cash & Equivalents crashed 94.18% in 2023, then surged 282.7% in 2025.
  • Year by year, Cash & Equivalents stood at $50.6 million in 2021, then tumbled by 42.45% to $29.1 million in 2022, then crashed by 63.4% to $10.6 million in 2023, then skyrocketed by 83.94% to $19.6 million in 2024, then surged by 179.16% to $54.7 million in 2025.
  • Business Quant data shows Cash & Equivalents for COHN at $54.7 million in Q3 2025, $26.0 million in Q2 2025, and $14.0 million in Q1 2025.